INDSWFTLABNSEInd-Swift Laboratories Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Mon, 15 Dec, 2025 · 18:33 IST

Ind-Swift gets EUDRA GMP certificate from Hungary for Punjab facility

Regulatory Product ApprovalBusiness Updates View source PDFExplain this filing

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.2%Reaction day
₹96.31
prior close
₹97.62
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-0.6% vs market
Pharmaceuticals peers, median of 159sector-0.4%-0.8% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.8
10m
+1.1
15m
+1.3
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.2-0.6-0.6-0.4-0.8
Next day
-2.6-1.5-1.1-1.2-1.4
2d
-2.2-1.8-0.4-1.3-0.9
3d
-2.9-0.6-2.3-0.4-2.5
4d
-1.6+0.8-2.4+0.1-1.7
5d
-3.4+0.8-4.3+0.3-3.7
1w
-5.3-0.2-5.0-0.6-4.7
15d
-2.9+1.1-4.0+0.9-3.8
1m
+15.3-3.5+18.8-2.6+17.8
2m
+50.1-3.2+53.4-4.3+54.4
3m
+43.8-12.8+56.6-11.5+55.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ind-Swift Laboratories' Global Business Unit formulations facility at Derabassi, Punjab has received a GMP compliance certificate from Hungary's National Center for Public Health and Pharmacy (NNGYK), following an EUDRA GMP inspection in November 2025. The certificate is valid for 3 years and opens access to European and other regulated markets. The facility already holds WHO-GMP, TGA Australia, MHRA UK, SAPRA South Africa, and EU-GMP certifications.

Likely market impact

Strengthens regulatory footprint enabling higher-value European exports, potentially supporting revenue growth and margin expansion from regulated markets.